ADILW | Adial Pharmaceuticals, Inc. WT EXP 073123 Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0009 - 0.0025
52 Week Range	0.0009 - 0.0025
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	5,182
Average Volume	N/A
Shares Outstanding	N/A
Market Cap	N/A
Sector
Industry
IPO Date	2018-07-27

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	0
Country	USA

ADILW's peers: BCDAW, BROGW, XBIOW, ADVWW, ATNFW

*Chart delayed

Analyzing fundamentals for ADILW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see ADILW Fundamentals page.

Watching at ADILW technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ADILW Technicals page.